A股異動丨豪悅護理跌停 上半年、Q2增收不增利 三費佔比上升明顯
豪悅護理(605009.SH)跌停,股價創今年4月中旬以來新低,總市值78.2億元。消息上,日前豪悅護理髮布2025年中報。公司營業總收入17.6億元,同比上升34.03%,歸母淨利潤1.48億元,同比下降23.47%。按單季度數據看,第二季度營業總收入8.49億元,同比上升26.07%,第二季度歸母淨利潤5787.26萬元,同比下降46.55%。本報告期豪悅護理三費佔比上升明顯,財務費用、銷售費用和管理費用總和佔總營收同比增幅達126.14%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.